本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mereo Biopharma Group Plc

0.3181
-0.0019-0.59%
成交量:38.26萬
成交額:12.21萬
市值:5,061.98萬
市盈率:-1.21
高:0.3256
開:0.3169
低:0.3149
收:0.3200
52周最高:3.05
52周最低:0.2000
股本:1.59億
流通股本:1.00億
量比:0.85
換手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-0.2629
每股收益(LYR):-0.2627
淨資產收益率:-82.21%
總資產收益率:-39.41%
市淨率:1.24
市盈率(LYR):-1.21

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report